欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Tyrosine Kinase-VEGFR-Cediranib
Cediranib

Chemical Structure : Cediranib

CAS No.: 288383-20-0

Cediranib (AZD2171;AZD 2171;AZD-2171)

货号: PC-42450Not For Human Use, Lab Use Only.

Cediranib (AZD2171) is a highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.

规格 价格 库存 数量
25 mg ¥1580 In stock
50 mg ¥2480 In stock
100 mg ¥3980 In stock
200 mg Get quote
1 g Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Cediranib (AZD2171) is a highly potent, orally bioavailable, pan-VEGFR inibitor with IC50 of 1, 5, 3 nM for VEGFR1, 2, 3, respectively.
Cediranib (AZD2171) also inhibits c-Kit and PDGFRβ with IC50 of 2 and 5 nM, >36-fold selectivity over PDGFR-α, >1000-fold over Flt-3 and EGFR.
Cediranib (AZD2171) inhibits VEGF-stimulated proliferation and KDR phosphorylation with IC50 of 0.4 and 0.5 nM in human umbilical vein endothelial cells.
Cediranib (AZD2171) inhibits angiogenesis, neovascular survival and tumor growth in vivo.

物理化学性质&存储条件

分子量 450.5053
分子式 C25H27FN4O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO: ≥ 49 mg/mL

Chemical Name/SMILES

Quinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-

参考文献

1. Wedge SR, et al. Cancer Res. 2005 May 15;65(10):4389-400.

2. Denduluri N, et al. Clin Breast Cancer. 2005 Dec;6(5):460-3.

3. Batchelor TT, et al. Cancer Cell. 2007 Jan;11(1):83-95.

4. Cao C, et al. Cancer Res. 2006 Dec 1;66(23):11409-15.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: